6851 - 6900 of 9038 Results
Title
Year
-
OPENTitle: N-type Ca2+ channels mediate the stimuli-dependent α-synuclein secretion in mouse striatumJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 276End Page: 276Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-025-01110-zBest OA location URL: https://www.nature.com/articles/s41531-025-01110-z.pdfCitation Count: 0
- Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition2019OPENTitle: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104577End Page: 104577Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104577Citation Count: 45
-
OPENTitle: A functionalized hydroxydopamine quinone links thiol modification to neuronal cell deathJournal Name: Redox BiologyPublisher: Elsevier BVVol: 28Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2019.101377Best OA location URL: https://doi.org/10.1016/j.redox.2019.101377Citation Count: 30
- Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutation2018RESTRICTEDTitle: Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutationJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 13Issue #: 4Start Page: 1009End Page: 1020Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11682-018-9920-2Citation Count: 16
-
OPENTitle: The Age at Onset of LRRK2 p. Gly2019Ser Parkinson's Disease Across Ancestries and Countries of OriginJournal Name: Annals of NeurologyPublisher: WileyVol: 99Issue #: 6Start Page: 1394End Page: 1404Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.78181Best OA location URL: https://doi.org/10.1002/ana.78181Citation Count: 0
-
RESTRICTEDTitle: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 724End Page: 735Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133481Citation Count: 0
-
OPENTitle: Network Connectivity Alterations across the MAPT Mutation Clinical SpectrumJournal Name: Annals of NeurologyPublisher: WileyVol: 94Issue #: 4Start Page: 632End Page: 646Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26738Citation Count: 7
- No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)2013RESTRICTEDTitle: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187Citation Count: 0
-
OPENTitle: Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 54Issue #:Start Page: 339End Page: 348Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.01.005Best OA location URL: https://doaj.org/article/3a6e644df03c4d82b68e076041de91dcCitation Count: 41
-
OPENTitle: Low‐variance RNAs identify Parkinson's disease molecular signature in bloodJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 813End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26205Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4439364Citation Count: 20
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 7Start Page: 1253End Page: 1263Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1877718X251356503Citation Count: 2
- Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative2026RESTRICTEDTitle: Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78249Citation Count: 0
-
OPENTitle: Disruption of the LRRK2 substrate RAB12 facilitates neurotransmission and causes hyperactivity in miceJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-026-01353-4Best OA location URL: https://doi.org/10.1038/s41531-026-01353-4Citation Count: 0
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p3.048Citation Count: 4
-
OPENTitle: Increasing Efficiency of Recruitment in Early Parkinson’s Disease Trials: A Case Study Examination of the STEADY-PD III TrialJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 4Start Page: 685End Page: 693Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171199Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171199?id=journal-of-parkinsons-disease%2Fjpd171199Citation Count: 20
-
OPENTitle: Precise disease heterogeneity and progression quantification in MSA and Parkinson’s disease using machine learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41598-026-45949-5Best OA location URL: https://www.nature.com/articles/s41598-026-45949-5_reference.pdfCitation Count: 0
- Media hype: Patient and scientific perspectives on misleading medical news2017RESTRICTEDTitle: Media hype: Patient and scientific perspectives on misleading medical newsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1319End Page: 1323Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26993Citation Count: 44
- Distinct biological underpinnings of Parkinson's disease motor subtypes: single-center study on pathway-stratified polygenic risk scores2025RESTRICTEDTitle: Distinct biological underpinnings of Parkinson's disease motor subtypes: single-center study on pathway-stratified polygenic risk scoresJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 137Issue #:Start Page: 107901End Page: 107901Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107901Citation Count: 1
-
OPENTitle: Targeted deletion ofGD3synthase protects againstMPTP‐induced neurodegenerationJournal Name: Genes, Brain and BehaviorPublisher: WileyVol: 16Issue #: 5Start Page: 522End Page: 536Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1111/gbb.12377Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/gbb.12377Citation Count: 22
-
OPENTitle: Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and AnalogsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 1Start Page: 119End Page: 135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00597Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10147382/pdf/nihms-1890246.pdfCitation Count: 65
- Importance of the initial response to GPi deep brain stimulation in dystonia: A nine year quality of life study2019RESTRICTEDTitle: Importance of the initial response to GPi deep brain stimulation in dystonia: A nine year quality of life studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 249End Page: 255Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.04.024Citation Count: 30
-
OPENTitle: Multi-parameter fluorescence lifetime imaging for high-noise neuroscience applicationsJournal Name: Biomedical Optics ExpressPublisher: Optica Publishing GroupVol: 17Issue #: 2Start Page: 816End Page: 816Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1364/boe.578337Best OA location URL: https://doi.org/10.1364/boe.578337Citation Count: 0
-
OPENTitle: CLIPPERS: A Treatable Cause of Spastic AtaxiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 212End Page: 214Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12602Citation Count: 2
-
OPENTitle: Sorting (Nexin-13) out Novel Insights into Endolysosomal Cholesterol ExportJournal Name: ContactPublisher: SAGE PublicationsVol: 5Issue #:Start Page: 251525642211145End Page: 251525642211145Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/25152564221114513Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/25152564221114513Citation Count: 2
-
OPENTitle: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligaseJournal Name: AutophagyPublisher: Informa UK LimitedVol: 21Issue #: 12Start Page: 2750End Page: 2770Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2025.2531025Best OA location URL: https://doi.org/10.1080/15548627.2025.2531025Citation Count: 4
-
OPENTitle: Dual-Task Performance in GBA Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2017Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2017/8582740Best OA location URL: http://downloads.hindawi.com/journals/pd/2017/8582740.pdfCitation Count: 5
-
OPENTitle: Updating MISEV: Evolving the minimal requirements for studies of extracellular vesiclesJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 14Start Page: e12182End Page: e12182Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12182Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12182Citation Count: 344
-
OPENTitle: The Interaction between HLA‐DRB1 and Smoking in Parkinson's Disease RevisitedJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1929End Page: 1937Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29133Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29133Citation Count: 13
- O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH2018RESTRICTEDTitle: O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACHJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 14Issue #: 7S_Part_11Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2018.06.2691Citation Count: 0
-
OPENTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/record/1831976Citation Count: 175
-
OPENTitle: Feasibility, Safety, and Compliance in a Randomized Controlled Trial of Physical Therapy for Parkinson's DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/795294Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/795294.pdfCitation Count: 33
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial2011RESTRICTEDTitle: AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 309End Page: 319Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70039-4Citation Count: 667
- Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia2021OPENTitle: Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementiaJournal Name: CortexPublisher: Elsevier BVVol: 139Issue #:Start Page: 99End Page: 115Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2021.03.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8119343Citation Count: 39
-
OPENTitle: Identification of a Putative α-synuclein Radioligand Using an in silico Similarity SearchJournal Name: Molecular Imaging and BiologyPublisher: Springer Science and Business Media LLCVol: 25Issue #: 4Start Page: 704End Page: 719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11307-023-01814-9Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10527666/pdf/nihms-1908506.pdfCitation Count: 16
-
OPENTitle: LRRK2 activation in idiopathic Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 451Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5429Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6344941Citation Count: 599
-
OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 38
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
-
OPENTitle: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort ExperienceJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 665End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191901Best OA location URL: https://escholarship.org/uc/item/1rb4t3mzCitation Count: 61
-
OPENTitle: Palliative Care and Parkinson's Disease: Time to Move Beyond CancerJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1325End Page: 1329Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28556Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8217287Citation Count: 24
-
OPENTitle: Using Qualitative Methods to Understand Physical Activity and Weight Management Among Bangladeshis in New York City, 2013Journal Name: Preventing Chronic DiseasePublisher: Centers for Disease Control and Prevention - Preventing Chronic DiseaseVol: 13Issue #:Start Page: E87End Page: E87Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.5888/pcd13.160077Best OA location URL: https://www.cdc.gov/pcd/issues/2016/pdf/16_0077.pdfCitation Count: 23
-
OPENTitle: Home-Based Augmented Reality Gait-and-Balance Therapy in Parkinson Disease: An Examination of Exercise IntensityJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2025.12.008Best OA location URL: https://doi.org/10.1016/j.apmr.2025.12.008Citation Count: 1
-
OPENTitle: Intact working memory in non‐manifesting LRRK2 carriers – an fMRI studyJournal Name: European Journal of NeurosciencePublisher: WileyVol: 43Issue #: 1Start Page: 106End Page: 112Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13120Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13120Citation Count: 20
- Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease2018RESTRICTEDTitle: Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 190Issue #:Start Page: 94End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.01.021Citation Count: 27
-
OPENTitle: TBK1 Induces the Formation of Optineurin Filaments That Condensate with Polyubiquitin and LC3 for Cargo SequestrationJournal Name: Advanced SciencePublisher: WileyVol: 13Issue #: 16Start Page: e09927End Page: e09927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/advs.202509927Best OA location URL: https://doi.org/10.1002/advs.202509927Citation Count: 0
- The Parkinson's Progression Markers Initiative: Why Then? Why Now?2026RESTRICTEDTitle: The Parkinson's Progression Markers Initiative: Why Then? Why Now?Journal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78192Citation Count: 0
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 32
-
OPENTitle: The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBACJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 617Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.aav1256Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7279956Citation Count: 25
-
OPENTitle: Visual Hallucinations in Eye Disease and Lewy Body DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 24Issue #: 5Start Page: 350End Page: 358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2015.10.007Best OA location URL: http://www.ajgponline.org/article/S1064748115002687/pdfCitation Count: 34
-
OPENTitle: Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseasesJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 15Start Page: 3500End Page: 3512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/dds161Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3392107Citation Count: 237
- LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP62012OPENTitle: LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6Journal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 22Start Page: 4966End Page: 4979Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1093/hmg/dds342Best OA location URL: https://academic.oup.com/hmg/article-pdf/21/22/4966/17257652/dds342.pdfCitation Count: 103